Top segments and regional performance

Last year, the company generated ‪41.29 B‬ EUR, the most of which — ‪38.67 B‬ EUR — came from its top-performing segment, Obesity and Diabetes Care, compared to ‪36.33 B‬ EUR the previous year. The greatest contribution came from United States, which accounted for ‪23.13 B‬ EUR last year, with ‪22.38 B‬ EUR the year before.